网站首页
专题首页
会议动态
专家访谈
热点聚焦
主题演讲
精彩视频
热点聚焦
学术领域
专题标签
临床聚焦
专题首页
» 临床聚焦
New Endpoints in HBV Drug Development
2016-03-02
Portal Vein Thrombosis in Cirrhotic and Non-cirrhotic Liver
2016-03-02
New Drugs to Overwhelm the Barriers to Eliminate HCV
2016-03-02
Welcome Message——Jinlin Hou
2016-03-02
AARC-ACLF, the Better Prognostic Score—AARC-ACLF Score predicts 30-day survival better than CLIF-SOFA
2016-03-02
LDV/SOF Efficacious in HCV Patients with Decompensated Cirrhosis
2016-03-02
VEL/SOF Effective in HCV Patients with Decompensated Cirrhosis
2016-03-02
Radiofrequency Ablation (RFA) Know-How in 2 Days — Juntendo University radiofrequency ablation (RFA) training program
2016-03-02
REP2139-Ca, a Promising NAP to Treat HBV
2016-03-02
At 38 years, just Young and Robust—25th APASL Opening Ceremony
2016-03-02
For HBV/HCV Co-infection Patients in DAA Era, Treat the Viruses both!
2016-03-02
Hepatitis B Treatment: Yesterday, Today and Tomorrow
2016-03-02
The Situation of Liver Diseases in Asian-Pacific countries and the Urgent Tasks for Beating HCV and HBV
2016-03-01
New Threat to Developed Countries: NAFLD Related HCC
2016-03-01
Unmet Need for the Patients with Chronic Hepatitis C
2016-03-01
Different Role of Liver Biopsy between Hepatitis B and C
2016-03-01
Reality or Dream: to Eradicate Hepatitis C and Hepatitis B
2016-03-01
首页
1
尾页